Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation

Human Reproduction

Volumn 19, Issue 8, 2004, Pages 1796-1799

  Grandone, E ^a   Colaizzo, D ^a   Vergura, P ^a   Cappucci, F ^a   Vecchione, G ^a   Bue, A Lo ^b   Cittadini, E ^c   Margaglione, M ^d  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Centro di Biologia della Riproduzione   (Italy)

^c Cattedra di Ostetricia e Ginecologia   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Age; Homocysteine; IVF; Thrombophilia; Thrombotic events

Indexed keywords

ANTITHROMBIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 5 LEIDEN; CLOMIFENE CITRATE; GONADOTROPIN; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL RESEARCH; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; GENE MUTATION; GENOTYPE; GROUPS BY AGE; HEALTH CENTER; HUMAN; OUTPATIENT; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREVALENCE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

EID: 4344587425     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh346     Document Type: Article

References (17)

1. Abbott RD, Curb JD, Rodriguez BL, Masaki KH, Popper JS, Ross GW and Petrovitch H (2003) Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke. J Clin Epidemiol 56,479-486.
2. Anderson FA, Jr and Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1),I9-16.
3. Arya R, Shehata HA, Patel RK, Sahu S, Rajasingam D, Harrington K, Nelson-Piercy C and Parsons JH (2001) Internal jugular vein thrombosis after assisted conception therapy. Br J Haematol 115,153-155.
4. Aurousseau MH, Samama MM, Belhassen A, Herve F and Hugues JN (1995) Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum Reprod 10,94-97.
5. Baumann P and Diedrich K (2000) Thromboembolic complications associated with reproductive endocrinologic procedures. Haematol/Oncol Clin North Amer 14,431-443.
6. Belaen B, Geerinckx K, Vergauwe P and Thys J (2001) Internal jugular vein thrombosis after ovarian stimulation: case report. Hum Reprod 16,510-512.
7. D'Angelo A and Selhub J (1997) Homocysteine and thrombotic disease. Blood 90,1-11.
8. Exner T, Triplett DA, Taberner D and Machin SJ (1991) Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 65,320-322.
9. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, Scianname N, Pavone G and Di Minno G (1997) Factor V Leiden is associated with repeated and recurrent fetal losses. Thromb Haemost 77,822-824.
10. Grandone E, Margaglione M, Colaizzo D, D'Andrea G, Cappucci G, Brancaccio V and Di Minno G (1998) Genetic susceptibility to pregnancy-related venous thromboembolism: role of Factor V Leiden, prothrombin G20210A and C677T methylenetetrahydrofolate reductase mutations. Am J Obstet Gynecol 179,1324-1328.
11. Kodama H, Fukuda J, Karube H, Matsui T, Shimuzu Y and Tanaka T (1996) Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril 3,417-424.
12. Loret de Mola JR, Kiwi R, Austin C and Goldfarb JM (2000) Subclavian deep vein thrombosis associated with the use of recombinant follicle-stimulating hormone (Gonal-F) complicating mild ovarian hyperstimulation syndrome. Fertil Steril 73,1253-1256.
13. Magera MJ, Lacey JM, Casetta B and Rinaldo P (1999) Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem 45,1517-1522.
14. Margaglione M, Brancaccio V, Giuliani N, D'Andrea G, Cappucci G, Iannaccone L, Vecchione G, Grandone E and Di Minno G (1998) Increased risk for venous thrombosis in carriers of the prothrombin G → A 20210 gene variant. Ann Intern Med 129,89-93.
15. Practice Commettee of the American Society for Reproductive Medicine (2003) Ovarian hyperstimulation syndrome. Fertil Steril 80,1309-1314.
16. Stewart JA, Hamilton PJ and Murdoch AP (1997) Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Hum Reprod 12,2167-2173.
17. Whelan JG III and Vlahos NF (2000) The ovarian hyperstimulation syndrome. Fertil Steril 73,883-896.